Abstract
The enzyme poly(ADP-ribose)polymerase (PARP) has a leader role in the DNA damage survey mechanisms by its nick-sensor function, but it is also involved in the early events of the programmed cell death, particularly during inflammatory injury, as a coactivator of NF-kB. In the present study, we evaluated the PARP involvement in the mechanisms of protection and/or cell death in rat astroglial cell cultures during the early phase of proinflammatory commitment after lipopolysaccharide and interferon gamma treatment. According with the recent findings that PARP-1 phosphorylation by MAPK/ERK-2 pathway seems to modulate PARP activation, in time course experiments we demonstrated that a very early PARP activation and expression is able to trigger a cell death pathway, DNA damage independent, during strong proinflammatory insults, maintaining its role of guardian of the genome stability only during the normal cell cycling.
Similar content being viewed by others
References
Kruman II, Schwartz EI (2008) DNA damage response and neuroprotection. Front Biosci 13:2504–2515. doi:10.2741/2862
Lee SM, Yune TY, Kim SJ et al (2004) Minocycline inhibits apoptotic cell death via attenuation of TNF-α expression following iNOS/NO induction by lipopolysaccaride in neuron/glia co-cultures. J Neurochem 91:568–578. doi:10.1111/j.1471-4159.2004.02780.x
Liu H, Colavitti R, Rovira II et al (2005) Redox-dependent transcriptional regulation. Circ Res 97:967–974. doi:10.1161/01.RES.0000188210.72062.10
Chan PH (2004) Mitochondria and neuronal death/survival signaling pathway in cerebral ischemia. Neurochem Res 29:1943–1949. doi:10.1007/s11064-004-6869-x
Nicoletti VG, Caruso A, Tendi EA et al (1998) Effect of nitric oxide synthase induction on the expression of mitochondrial respiratory chain enzyme subunits in mixed cortical and astroglial cell cultures. Biochimie 80:871–881. doi:10.1016/S0300-9084(00)88882-3
Bolaños JP, Almeida A, Stewart V et al (1997) Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem 68:2227–2240
De Murcia JM, Niedergang C, Trucco C et al (1997) Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci USA 94:7303–7307. doi:10.1073/pnas.94.14.7303
D’Amours D, Desnoyers S, D’Silva I et al (1999) Poly(ADP-ribosyl)ation reactions in the regulation of nuclear function. Biochem J 342:249–268. doi:10.1042/0264-6021:3420249
Herceg Z, Wang ZQ (2001) Function of poly(ADP-ribose)polimerase (PARP) in DNA repair, genomic integrity and cell death. Mutat Res 477:97–110. doi:10.1016/S0027-5107(01)00111-7
Lindhal T, Sah MS, Poirier GG et al (1995) Posttranslational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci 20:405–411. doi:10.1016/S0968-0004(00)89089-1
Simbulan-Rosenthal CM, Rosenthal DS, Hilz H et al (1996) The expression of poly(ADP-ribose) polymerase during differentiation-linked DNA replication reveals that this enzyme is a component of the multiprotein DNA replication complex. Biochemistry 35:11622–11633. doi:10.1021/bi953010z
Yakovlev AG, Wang G, Stoica BA et al (2000) A role of the Ca2+/Mg2+-dependent endonuclease in apoptosis and its inhibition by poly(ADP-ribose) polymerase. J Biol Chem 275:21302–21308. doi:10.1074/jbc.M001087200
Bauer PI, Chen H, Kenesi E, Kenessey I et al (2001) Molecular interaction between Poly(ADP-ribose) polimerase (PARP-1) and topoisomerase I: identification of topology of binding. FEBS Lett 506:239–242. doi:10.1016/S0014-5793(01)02919-2
Dantzer F, Schreiber V, Niedergang C et al (1999) Involvement of Poly(ADP-ribose) polimerase in base excision repair. Biochimie 81:69–75. doi:10.1016/S0300-9084(99)80040-6
Le Page F, Schreiber V, Dhérin C et al (2003) Poly(ADP-ribose) polymerase-1 (PARP-1) is required in murine cell lines for base excision repair of oxidative DNA damage in the absence of DNA polymerase. J Biol Chem 278:18471–18477. doi:10.1074/jbc.M212905200
Shall S, De Murcia G (2000) Poly(ADP-ribose) polimerase-1: what we have learned from the deficient mouse model? Mutat Res 460:1–15
Eliasson MJL, Sampei K, Mandir AS et al (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischaemia. Nat Med 3:1089–1095. doi:10.1038/nm1097-1089
Ha HC, Snyder SH (1999) Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 96:13978–13982. doi:10.1073/pnas.96.24.13978
Kamanaka Y, Kondo K, Ikeda Y et al (2004) Neuroprotective effects of ONO-1924H, an inhibitor of poly ADP-ribose polymerase (PARP), on cytotoxicity of PC12 cells and ischemic cerebral damage. Life Sci 76:151–162. doi:10.1016/j.lfs.2004.04.057
Cozzi A, Cipriani G, Fossati S et al (2006) Poly(ADP-ribose) accumulation and enhancement of postischemic brain damage in 110-kDa poly(ADP-ribose) glycohydrolase null mice. J Cereb Blood Flow Metab 26:684–695. doi:10.1038/sj.jcbfm.9600222
Moroni F (2008) Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage. Curr Opin Pharmacol 8:96–103. doi:10.1016/j.coph.2007.10.005
Mandir AS, Przedborski S, Jackson-Lewis V et al (1999) Poly(ADP-ribose) polymerase activation mediates 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci USA 96:5774–5779. doi:10.1073/pnas.96.10.5774
Cosi C, Marie M (1999) Implication of Poly(ADP-ribose) polymerase (PARP) in neurodegeneration and brain energy metabolism. Decreases in mouse brain NAD+ and ATP caused by MPTP are prevented by the PARP inhibitor benzamide. Ann N Y Acad Sci 890:227–239. doi:10.1111/j.1749-6632.1999.tb07998.x
Cosi C, Suzuki H, Milani D et al (1994) Poly(ADP-ribose) polymerase early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J Neurosci Res 39:38–46. doi:10.1002/jnr.490390106
Pieper AA, Blackshaw S, Clements EE et al (2000) Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. Proc Natl Acad Sci USA 97:1845–1850. doi:10.1073/pnas.97.4.1845
Meli E, Pangallo M, Picca R et al (2004) Differential role of (ADP-ribose) polymerase-1 in apoptotic and necrotic death induced by mild or intense NMDA exposure in vitro. Mol Cell Neurosci 25:172–180. doi:10.1016/j.mcn.2003.09.016
Chiarugi A, Moskowitz MA (2003) Poly(ADP-ribose) polymerase-1 activity promotes NF-kB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem 85:306–317. doi:10.1046/j.1471-4159.2003.01684.x
Zheng J, Devalaraja-Narashimha K, Singaravelu K et al (2005) Poly(ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injury. Am J Physiol Renal Physiol 288:F387–F398. doi:10.1152/ajprenal.00436.2003
Oliver FJ, de Menissier Murcia J, Nacci C et al (1999) Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 18:4446–4454. doi:10.1093/emboj/18.16.4446
Veres B, Radnai B, Gallyas F et al (2004) Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice. J Pharmacol Exp Ther 310:247–255. doi:10.1124/jpet.104.065151
Yu Z, Kuncewicz T, Dubinsky WP et al (2006) Nitric oxide-dependent negative feedback of PARP-1 trans-activation of the inducible nitric-oxide synthase gene. J Biol Chem 281:9101–9109. doi:10.1074/jbc.M511049200
Olszanecki RA, Gêbska J, Jawieñ A et al (2006) Inhibition of NOS-2 induction in LPS-stimulated J774.2 cells by 1, 5-isoquinolinediol, an inhibitor of PARP. J Physiol Pharmacol 57:109–117
Bursztajn S, Feng JJ, Berman SA et al (2000) Poly ADP-ribose polymerase induction is an early signal of apoptosis in human neuroblastoma. Brain Res Mol Brain Res 76:363–376. doi:10.1016/S0169-328X(00)00026-7
Koh DW, Dawson TM, Dawson VL (2005) Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res 52:5–14. doi:10.1016/j.phrs.2005.02.011
Yu SW, Wang H, Poitras MF et al (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297:259–263. doi:10.1126/science.1072221
Soldani C, Scovassi AI (2002) Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 7:321–328. doi:10.1023/A:1016119328968
Petrilli V, Herceg Z, Hassa PO et al (2004) Noncleavable Poly(ADP-ribose polymerase-1 regulates the inflammation response in mice. J Clin Invest 114:1072–1081
Cohen-Armon M (2007) PARP-1 activation in the ERK signaling pathway. Trends Pharmacol Sci 28:556–560. doi:10.1016/j.tips.2007.08.005
Avola R, Condorelli DF, Surrentino S et al (1988) Effect of epidermal growth factor and insulin on DNA, RNA and cytosckeletal protein labeling in primary rat astroglial cell cultures. J Neurosci Res 19:230–238. doi:10.1002/jnr.490190208
Lowry OM, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Laemmli UK (1970) Cleavage of the structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685. doi:10.1038/227680a0
Spina-Purrello V, Avola R, Condorelli DF et al (1990) ADP-ribosylation of proteins in brain regions of rats during postnatal development. Int J Dev Neurosci 8:167–174. doi:10.1016/0736-5748(90)90007-O
Masmoudi A, Islam F, Mandel P (1988) ADP-ribosylation of highly purified rat brain mitochondria. J Neurochem 51:188–193. doi:10.1111/j.1471-4159.1988.tb04854.x
Henry RJ, Chiamori H, Coolub OJ, Berkman S (1960) Revised spectrophotometric method for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase and lactic acid dehydrogenase. Am J Clin Pathol 34:381–398
Mander P, Brown GC (2005) Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration. J Neuroinflammation 2(20):1–15
Von Bernhardi R (2007) Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotox Res 12:215–232
Dell’Albani P, Santangelo R, Torrisi L, Nicoletti VG et al (2001) JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures. J Neurosci Res 65:417–424. doi:10.1002/jnr.1169
Smets LA, Loesberg C, Janssen M, Van Rooij H (1990) Intracellular inhibition of mono(ADP-ribosylation) by meta-iodobenzylguanidine: specificity, intracellular concentration and effects on glucocorticoid-mediated cell lysis. Biochim Biophys Acta 1054:49–55. doi:10.1016/0167-4889(90)90204-Q
Le Page C, Sanceau J, Drapier JC, Wietzerbin J (1998) Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF-kB activation. Biochem Biophys Res Commun 243:451–457. doi:10.1006/bbrc.1998.8113
Di Meglio S, Tramontano F, Cimmino G et al (2004) Dual role for poly(ADP-ribose)polymerase-1 and -2 and poly(ADP-ribose)glycohydrolase as DNA-repair and pro-apoptotic factors in rat germinal cells exposed to nitric oxide donors. Biochim Biophys Acta 1692:35–44. doi:10.1016/S0167-4889(04)00073-4
Nicoletti VG, Giuffrida-Stella AM (2003) Role of PARP under stress conditions: cell death or protection? Neurochem Res 28:187–194. doi:10.1023/A:1022316914492
Endres M, Scott G, Namura S et al (1998) Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion. Neurosci Lett 248:41–44. doi:10.1016/S0304-3940(98)00224-9
Chiarugi A (2002) Poly(ADP-ribose) polymerase: killer or conspirator? The ‘suicide hypothesis’ revisited. Trends Pharmacol Sci 23:122–129. doi:10.1016/S0165-6147(00)01902-7
Moroni F, Meli E, Peruginelli F et al (2001) Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ 8:921–932. doi:10.1038/sj.cdd.4400884
Iwashita A, Yamazaki S, Mihara K et al (2004) Neuroprotective effects of a novel poly(ADP-ribose) polymerase-1 inhibitor, 2-[3-[4-(4-chlorophenyl)-1-piperazinyl] propyl]-4(3H)-quinazolinone (FR255595), in an in vitro model of cell death and in mouse 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson’s disease. J Pharmacol Exp Ther 309:1067–1078. doi:10.1124/jpet.103.064642
Outeiro TF, Grammatopoulos TN, Altmann S et al (2007) Pharmacological inhibition of PARP-1 reduces alpha-synuclein- and MPP(+)-induced cytotoxicity in Parkinson’s disease in vitro models. Biochem Biophys Res Commun 357:596–602. doi:10.1016/j.bbrc.2007.03.163
Adamczyk A, Jeśko H, Strosznajder RP (2005) Alzheimer’s disease related peptides affected cholinergic receptor mediated poly(ADP-ribose) polymerase activity in the hippocampus. Folia Neuropathol 43:139–142
Wang SJ, Wang SH, Song ZF et al (2007) Poly(ADP-ribose) polymerase inhibitor is neuroprotective in epileptic rat via apoptosis-inducing factor and Akt signaling. NeuroReport 18:1285–1289. doi:10.1097/WNR.0b013e32826fb3a5
De la Lastra CA, Villegas I, Sánchez-Fidalgo S (2007) Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications. Curr Pharm Des 13:933–962. doi:10.2174/138161207780414241
Fossati S, Cipriani G, Moroni F, Chiarugi A (2007) Neither energy collapse nor transcription underlie in vitro neurotoxicity of poly(ADP-ribose) polymerase hyper-activation. Neurochem Int 50:203–210. doi:10.1016/j.neuint.2006.08.009
Besson VC, Margaill I, Plotkine M, Marchand-Verrecchia C (2003) Deleterious activation of poly(ADP-ribose)polymerase-1 in brain after in vivo oxidative stress. Free Radic Res 37:1201–1208. doi:10.1080/10715760310001612568
Benchoua A, Couriaud C, Guégan C et al (2002) Active caspase-8 translocates into the nucleus of apoptotic cells to inactivate poly(ADP-ribose) polymerase-2. J Biol Chem 277:34217–34222. doi:10.1074/jbc.M203941200
Viswanath V, Wu Y, Boonplueang R (2001) Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson’s disease. J Neurosci 21:9519–9528
Pleschke JM, Kleczkowska HE, Strohm M, Althaus FR (2000) Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J Biol Chem 275:40974–40980. doi:10.1074/jbc.M006520200
Audebert M, Calsou P (2008) Effect of double-strand break DNA sequence on the PARP-1 NHEJ pathway. Biochem Biophys Res Commun 369(3):982–988
Simbulan-Rosenthal CM, Ly DH, Rosenthal DS et al (2000) Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose). Proc Natl Acad Sci USA 97:11274–11279. doi:10.1073/pnas.200285797
Cardoso RS, Espanhol AR, Passos GAS, Sakamoto-Hojo ET (2002) Differential gene expression in γ-irradiated BALB/3T3 fibroblasts under the influence of 3-aminobenzamide, an inhibitor of PARP enzyme. Mutat Res 508:33–40. doi:10.1016/S0027-5107(02)00141-0
Yang YG, Cortes U, Patnaik S et al (2004) Ablation of PARP-1 does not interfere with the repair of DNA double-strand breaks, but compromises the reactivation of stalled replication forks. Oncogene 23:3872–3882. doi:10.1038/sj.onc.1207491
Malanga M, Althaus FR (2004) Poly(ADP-ribose) reactivates stalled DNA topoisomerase I and induces DNA strand break resealing. J Biol Chem 279:5244–5248. doi:10.1074/jbc.C300437200
Malanga M, Althaus FR (2005) The role of poly(ADP-ribose) in the DNA damage signaling network. Biochem Cell Biol 83:354–364. doi:10.1139/o05-038
Haince JF, McDonald D, Rodrigue A et al (2008) PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites. J Biol Chem 283:1197–1208. doi:10.1074/jbc.M706734200
Vodenicharov MD, Sallmann FR, Satoh MS, Poirier G (2000) Base excision repair is efficient in cells lacking Poly(ADP-ribose) polymerase 1. Nucleic Acids Res 28:3887–3896. doi:10.1093/nar/28.20.3887
Chatterjee S, Berger NA (1994) Growth-phase-dependent response to DNA damage in poly (ADP-ribose) polymerase deficient cell lines: based for a new hypothesis describing the role of poly (ADP-ribose) polymerase in DNA replication and repair. Mol Cell Biochem 138:61–69. doi:10.1007/BF00928444
Ghabreau L, Roux JP, Frappart PO et al (2004) Poly(ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors. Int J Cancer 109:317–321. doi:10.1002/ijc.11731
Visochek L, Steingart RA, Vulih-Shultzman I et al (2005) PolyADP-ribosylation is involved in neurotrophic activity. J Neurosci 25:7420–7428. doi:10.1523/JNEUROSCI.0333-05.2005
Yoon S, Seger R (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21–44. doi:10.1080/02699050500284218
Wang ZQ, Wu DC, Huang FP, Yang GY (2004) Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia. Brain Res 996:55–66. doi:10.1016/j.brainres.2003.09.074
Chu CT, Levinthal DJ, Kulich SM et al (2004) Oxidative neuronal injury. The dark side of ERK1/2. Eur J Biochem 271:2060–2066. doi:10.1111/j.1432-1033.2004.04132.x
Szabo C, Pacher P, Swanson RA (2006) Novel modulators of poly(ADP-ribose) polymerase. Trends Pharmacol Sci 27:626–630. doi:10.1016/j.tips.2006.10.003
Ethier C, Labelle Y, Poirier GG (2007) PARP-1-induced cell death through inhibition of the MEK/ERK pathway in MNNG-treated HeLa cells. Apoptosis 12:2037–2049. doi:10.1007/s10495-007-0127-z
Kauppinen TM, Chan WY, Won Suh S et al (2006) Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases. Proc Natl Acad Sci USA 103:7136–7141. doi:10.1073/pnas.0508606103
Acknowledgements
A special acknowledge goes to our scientific guide Prof. Anna Maria Giuffrida-Stella, that spent her life for the science and introduced us in this exciting world. This work was realized with the financial support of “Ricerca Ateneo”, University of Catania, FIRB RBNE03PX83, PRIN prot. 2005054147.
Author information
Authors and Affiliations
Corresponding author
Additional information
Special issue article in honor of Dr. Anna Maria Giuffrida-Stella.
Rights and permissions
About this article
Cite this article
Spina-Purrello, V., Patti, D., Giuffrida-Stella, A.M. et al. Parp and Cell Death or Protection in Rat Primary Astroglial Cell Cultures Under LPS/IFNγ Induced Proinflammatory Conditions. Neurochem Res 33, 2583–2592 (2008). https://doi.org/10.1007/s11064-008-9835-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-008-9835-1